e-learning
resources
ERJ
2002
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
iNOS depletion completely diminishes reactive nitrogen-species formation after an allergic response
Koarai A., Ichinose M., Sugiura H., Tomaki M., Watanabe M., Yamagata S., Komaki Y., Shirato K., Hattori T.
Source:
Eur Respir J 2002; 20: 609-616
Journal Issue:
September
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Koarai A., Ichinose M., Sugiura H., Tomaki M., Watanabe M., Yamagata S., Komaki Y., Shirato K., Hattori T.. iNOS depletion completely diminishes reactive nitrogen-species formation after an allergic response. Eur Respir J 2002; 20: 609-616
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen
Source: Eur Respir J 2003; 21: 394-400
Year: 2003
L-Arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction
Source: Eur Respir J 2009; 34: 191-199
Year: 2009
Increased nitric oxide production by neutrophils in bronchial asthma
Source: Eur Respir J 2001; 17: 868-871
Year: 2001
Neurokinins and nitric oxide modulate airway remodeling in a model of lung allergic inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 578s
Year: 2005
Lactose-β-sitosterol inhibits ovalbumin-induced asthmatic inflammation with no influence on nitric oxide pathway
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Inhibitors of NADPH-oxidase or nitric oxide synthase prevent airway hyperresponsiveness but not allergic inflammation in mice
Source: Eur Respir J 2001; 18: Suppl. 33, 265s
Year: 2001
Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma
Source: Eur Respir J 2006; 27: 951-956
Year: 2006
Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge
Source: Eur Respir J 2006; 27: 1152-1159
Year: 2006
Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms
Source: Eur Respir J 2002; 20: 841-845
Year: 2002
Differential assessment of airway inflammation and anti-inflammatory treatment in asthma by measurements of exhaled nitric oxide (NO) derived from peripheral
versus
central airways
Source: Eur Respir J 2003; 22: Suppl. 45, 449s
Year: 2003
Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma
Source: Eur Respir J 2001; 18: 635-639
Year: 2001
iNOS-derived nitric oxide modulates inflammatory cell apoptosis in a model of chronic allergic pulmonary inflammation in guinea pigs
Source: Eur Respir J 2006; 28: Suppl. 50, 760s
Year: 2006
Exhaled nitric oxide and lower airway involvement in persistent rhinitis
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers
vs
induced sputum
Year: 2006
Combined effects of type 2 inflammation and lung function on exhaled nitric oxide ability to reflect asthma control
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
Inducible nitric oxide synthase inhibition modulates lung tissue extracellular matrix remodelling induced by chronic allergic inflammation
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007
Modulation of chronic airway inflammation in guinea pigs by oral tolerance: effects in lung mechanics, cellular infiltration and nitric oxide production
Source: Eur Respir J 2002; 20: Suppl. 38, 382s
Year: 2002
Exhaled nitric oxide is a useful marker of airway hyperreactivity in patients with chronic cough
Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking
Year: 2005
Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma
Source: Eur Respir J 2001; 18: 444-450
Year: 2001
Regulated lung-specific overexpression of nitric oxide induces airway hyperresponsiveness in mice
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002
The clinical importance of measuring airway inflammation
Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept